Swiss - Delayed Quote CHF
Idorsia Ltd (IDIA.SW)
2.0150
+0.0150
+(0.75%)
At close: June 6 at 5:31:34 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-312,602
-370,232
-629,296
-859,108
-589,895
Investing Cash Flow
4,629
305,057
632,614
743,901
-53,257
Financing Cash Flow
24,456
26,108
-197
162,310
604,146
End Cash Position
51,333
106,376
145,052
145,998
101,352
Capital Expenditure
-17,407
-17,990
-9,398
-27,058
-30,931
Issuance of Capital Stock
--
--
0
360
10,000
Issuance of Debt
--
26,499
60,000
161,950
594,564
Repayment of Debt
-887
-311
-60,000
0
--
Repurchase of Capital Stock
--
-80
-197
0
-418
Free Cash Flow
-330,009
-388,222
-638,694
-886,166
-620,826
12/31/2021 - 6/16/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SANN.SW Santhera Pharmaceuticals Holding AG
13.86
+5.48%
NWRN.SW Newron Pharmaceuticals S.p.A.
7.70
+5.19%
BSLN.SW Basilea Pharmaceutica AG
50.40
+2.44%
RLF.SW Relief Therapeutics Holding SA
2.2100
0.00%
MOLN.SW Molecular Partners AG
2.9900
+1.36%
BION.SW BB Biotech AG Ord
30.85
+0.49%
XLS.SW Xlife Sciences AG
19.75
+1.28%
ACIU AC Immune SA
2.0400
+17.92%
22UA.DE BioNTech SE
96.50
-0.82%
ADXN.SW Addex Therapeutics Ltd
0.0606
+6.32%